AMAM
Ambrx Biopharma
485.88%
$1.70 - $9.96
Feb 7th 2023 - Mar 21st 2023
Mar, 13, 2023
$AMAM They cure prostate and breast cancer ๐ฒ100 IMHO
Feb, 23, 2023
$AMAM a trial for cancer is on going with good pos... See more
MACK
Merrimack Pharmaceuticals Inc
-2.04%
$11.74 - $11.50
Feb 6th 2023 - Mar 20th 2023
Nov, 14, 2022
$MACK $THER Ther a great buy now..with cancer ... See more
Nov, 11, 2022
I love my cancer plays.
TCBP
TC BioPharm Holdings Ltd
-46.03%
$5.67 - $3.06
Feb 7th 2023 - Mar 21st 2023
Feb, 3, 2023
Successful 2b/3 trial for cancer drug.
Jan, 31, 2023
"Cell therapies continue to present new promi... See more
Mar, 13, 2023
$AMAM They cure prostate and breast cancer ๐ฒ100 IMHO
Feb, 23, 2023
$AMAM a trial for cancer is on going with good positive results already.
Feb, 21, 2023
$AMAM prostate cancer drug, could be $100 in time, impressive gain on a red index day, going way higher ! !
Feb, 21, 2023
$AMAM a cancer play with good data recently I am long term bullish.
Feb, 21, 2023
$AMAM LETS DRIVE THIS CANCER STOCK TO ZERO! !
Jan, 11, 2023
$AMAM $THER Ther stock so many good news ..going to be bsck in dollars or take over Cancer tests and treatment options on theralink.com
Dec, 30, 2022
$AMAM $50 stock , breast cancer cure! !
Dec, 16, 2022
Now, this very well could be next blockbuster drug in cancer.
Dec, 14, 2022
$PBLA is the cheapest cancer stock on the market, multi-bagger runner, better opportunity than $amam here
Nov, 14, 2022
$MACK $THER Ther a great buy now..with cancer payment from.medicare https://www.prnewswire.com/news-releases/theralink-technologies-receives-final-medicare-reimbursement-rate-determination-and-ptan-enrollment-301676353.html?tc=eml_cleartime
Nov, 11, 2022
I love my cancer plays.
Nov, 10, 2022
phase 3 pancreatic cancer positive results.
Nov, 10, 2022
This is indeed exciting for the ovarian cancer field, as well as patients suffering from other types of WT1+ malignancies,โ concluded Dr. Bastos.
Nov, 10, 2022
New, proven pancreatic cancer treatment that improves overall survival.
Nov, 9, 2022
$MACK Pancreatic cancer Phase 3 success โ โ โ
Feb, 3, 2023
Successful 2b/3 trial for cancer drug.
Jan, 31, 2023
"Cell therapies continue to present new promise with exciting breakthroughs happening throughout the vertical and TC BioPharm continues as a leader in the allogeneic gamma delta t-cellspace.
Jan, 23, 2023
Phase 2/3 successful cancer drug .
Jan, 20, 2023
Phase 2/3 successful cancer research .